Regenicin, Inc. Debt Instrument, Convertible, Beneficial Conversion Feature
Regenicin, Inc. reported Debt Instrument, Convertible, Beneficial Conversion Feature of $251.21 thousand for the 12-month period ending 2010-09-30, per its 10-K filed 2014-01-14.
Discontinued › Notes › Debt Instruments
us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature · last filed 2014-01-14
- Regenicin, Inc. debt instrument, convertible, beneficial conversion feature for fiscal 2010 was $251.21K.
| Period end | Debt Instrument, Convertible, Beneficial Conversion Feature 12 month |
|---|---|
| 2010-09-30 | $251.21K 10-K · filed 2014-01-14 |